First clinical inflammatory demyelinating events of the central nervous system in a population aged over 70 years: A multicentre study.
Sign Up to like & getrecommendations! Published in 2019 at "Multiple sclerosis and related disorders"
DOI: 10.1016/j.msard.2018.12.016
Abstract: BACKGROUND Few data are available regarding patients with very late-onset inflammatory demyelinating events. (VLO-IDE). OBJECTIVES The aim of this study was to describe the clinical, biological, and radiological characteristics and aetiological diagnosis of very late… read more here.
Keywords: events central; inflammatory demyelinating; aged years; study ... See more keywords
Demyelinating events following anti‐tumor necrosis factor alpha therapy: Rare but challenging to treat
Sign Up to like & getrecommendations! Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15318
Abstract: Demyelinating events are listed as adverse events with tumor necrosis factor alpha inhibitors (TNFi), but epidemiological studies have provided partly conflicting risk estimates. Furthermore, studies examining long‐term outcomes of demyelinating events associated with TNFi are… read more here.
Keywords: tumor necrosis; necrosis factor; factor alpha; demyelinating events ... See more keywords
CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Neurology"
DOI: 10.3389/fneur.2022.1018785
Abstract: Background Vaccinations provided the most effective tool to fight the SARS-CoV-2 pandemic. It is now well established that COVID-19 vaccines are safe for the general population; however, some cases of rare adverse events following immunization… read more here.
Keywords: nmosd mogad; cns inflammatory; covid vaccines; vaccine ... See more keywords